Table 2.
b CL | c ML | |
---|---|---|
Male |
19/24 |
6/10 |
Female |
5/24 |
4/10 |
Age (years) |
38.5 ± 15.1 |
57.2 ± 17.9 |
Number of lesions |
3.5 ± 5.0 |
_ |
Size of Lesions (cm) |
2.7 ± 2.2 |
_ |
Time of lesions (months) |
7.2 ± 10.2 |
117.0 ± 51.0 |
d
MST (mm) |
16.1 ± 7.6 |
21.4 ± 13.8 |
Positive diagnostic test results% (positive/total tested) | ||
e
PCR |
83.3 (20/24) |
87.5 (7/8) |
f
IHC |
69.6 (16/23) |
66.6 (6/9) |
g
IFI |
41.2 (7/17) |
50.0 (4/8) |
MST | 76.2 (16/21) | 100 (8/8) |
aThirty four ATL patients who were assisted at Hospital de Doenças Tropicais Anuar Auad (Goiânia - Goiás, West Central, Brazil), 24 with bCL (Cutaneous Leishmaniasis) and 10 with cML (mucosal leishmaniasis). dMST: Montenegro skin test; ePCR: polymerase chain reaction for Leishmania genus; fIHC: histopathological exam with immunohistochemistry for amastigotes; gIFI: indirect immunofluorescence; 21 patients were from West Central region of Brazil (including 9 with ML; one was from South East); 10 from North and one from North East.